Guardant Health
GH
#3106
Rank
โ‚น333.69 B
Marketcap
โ‚น2,701
Share price
1.73%
Change (1 day)
19.00%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -โ‚น42.74 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น0.69 Billion. In 2023 the company made an earning of -โ‚น40.83 Billion, an increase over its 2022 earnings that were of -โ‚น55.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น42.74 Billion4.66%
2023 -โ‚น40.83 Billion-26.73%
2022 -โ‚น55.73 Billion69.96%
2021 -โ‚น32.79 Billion56.35%
2020 -โ‚น20.98 Billion252.69%
2019 -โ‚น5.95 Billion-17.22%
2018 -โ‚น7.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น18.12 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น2.7 Billion-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA